See the DrugPatentWatch profile for Celebrex
The stock performance of Celebrex (celecoxib) is tied to its manufacturer, Pfizer. While direct stock information for a specific drug like Celebrex is not typically available, investors track the performance of the pharmaceutical company as a whole.
How is Celebrex performing commercially?
Celebrex is an established nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Its commercial performance contributes to Pfizer's overall revenue.
When does Celebrex's patent protection expire?
The original patents for celecoxib have long expired, allowing for the availability of generic versions. This means that competition from generic manufacturers has impacted the market for branded Celebrex. Information on patent expiry dates for specific drugs and their implications can be found on sites like DrugPatentWatch.com [1].
What are the alternatives to Celebrex?
Numerous other NSAIDs are available, both prescription and over-the-counter, including ibuprofen, naproxen, and diclofenac. Other pain management options may include acetaminophen, other classes of pain relievers, and non-pharmacological therapies.
Who manufactures Celebrex?
Pfizer Inc. is the manufacturer of Celebrex.
What are the key clinical uses for Celebrex?
Celebrex is prescribed for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used for acute pain in adults and for primary dysmenorrhea.
What are the main risks and side effects associated with Celebrex?
Like other NSAIDs, Celebrex carries risks of cardiovascular thrombotic events, myocardial infarction, and stroke. It can also cause gastrointestinal bleeding, ulceration, and perforation. Other common side effects include abdominal pain, diarrhea, indigestion, gas, and headache. Patients with a history of heart disease or those taking other NSAIDs may face increased risks [2].
How does Celebrex compare to other COX-2 inhibitors?
Celebrex is a selective COX-2 inhibitor, distinguishing it from non-selective NSAIDs that inhibit both COX-1 and COX-2 enzymes. This selectivity was designed to reduce the gastrointestinal side effects associated with traditional NSAIDs, though cardiovascular risks remain a concern [2].
What is the regulatory status of Celebrex?
Celebrex is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for its indicated uses. Its labeling includes warnings and precautions regarding its risks, particularly cardiovascular and gastrointestinal issues [2].
What is the pricing of Celebrex and its generic versions?
The price of branded Celebrex is typically higher than its generic counterparts. Generic celecoxib is widely available, offering a more cost-effective option for patients and healthcare systems.
How does generic competition affect the market for Celebrex?
The entry of generic celecoxib has significantly increased market competition, leading to lower prices for the drug and potentially impacting the sales volume and revenue generated by branded Celebrex for Pfizer.
What is the mechanism of action for Celebrex?
Celebrex works by inhibiting the cyclooxygenase-2 (COX-2) enzyme. This enzyme plays a role in the synthesis of prostaglandins, which are mediators of inflammation and pain [2].
What patient concerns are relevant to Celebrex usage?
Patients often inquire about the safety profile of Celebrex, particularly regarding heart health and gastrointestinal issues. Understanding the appropriate dosage, potential drug interactions, and when to seek medical attention for side effects are common patient concerns.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020927s036,021240s027,021422s021,021802s017lbl.pdf